PROTEINA CO.,LTD. Logo

PROTEINA CO.,LTD.

A biotech firm specializing in proteomics for drug discovery and diagnostics in oncology.

468530 | KO

Overview

Corporate Details

ISIN(s):
KR7468530001
LEI:
Country:
South Korea
Address:
서울특별시 구로구 디지털로33길 11 구로동, 에이스테크노타워8차 13층 1301호, 구로구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PROTEINA CO., LTD. is a biotechnology company specializing in proteomics, focusing on the analysis of protein-protein interactions (PPI). Established in 2015, the company develops technologies to drive next-generation precision therapies and diagnostics. Its core innovation is the proprietary SPID (Single-molecule Protein Interaction Detection) platform, which enables real-time, high-resolution detection of protein interactions at the single-molecule level with unmatched sensitivity. PROTEINA's mission is to revolutionize protein analysis to facilitate the discovery of new drug candidates and the development of effective diagnostic approaches, particularly in oncology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-17 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 10.7 KB
2025-09-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 61.0 KB
2025-09-10 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 76.5 KB
2025-09-08 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 77.6 KB
2025-09-04 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 77.3 KB
2025-09-04 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 18.1 KB
2025-09-03 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 66.0 KB
2025-08-27 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 72.0 KB
2025-08-21 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.2 MB
2025-08-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-08-05 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 146.2 KB
2025-08-05 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-08-05 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-08-05 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB

Automate Your Workflow. Get a real-time feed of all PROTEINA CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PROTEINA CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PROTEINA CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea
007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea
293780
Aptahem AB Logo
Develops RNA aptamers to treat acute, life-threatening conditions like sepsis.
Sweden
APTA
Aptamer Sciences Inc Logo
Develops aptamer-based therapeutics and diagnostics for oncology and solid tumors.
South Korea
291650
Aptevo Therapeutics Inc. Logo
Developing multi-specific antibody immunotherapies for hematologic and solid tumor cancers.
United States of America
APVO
Aptorum Group Ltd Logo
Biopharma developing novel therapeutics for oncology, infectious and metabolic diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Develops oral film drugs for CNS disorders and severe allergies.
United States of America
AQST
Arbutus Biopharma Corp Logo
A clinical-stage virology company developing a functional cure for chronic hepatitis B (HBV).
United States of America
ABUS
Arcellx, Inc. Logo
Engineering controllable cell therapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway
ABS

Talk to a Data Expert

Have a question? We'll get back to you promptly.